Among CD4+ T cells, the balance between anti-inflammatory Treg cells and pro-inflammatory Th17/Th1 cells is closely associated with the progression and prognosis of IBD (Britton et al., 2019; Lee et al., 2020). This evidence concerns the gene CD4 and inflammatory bowel disease.